OTTAWA, Feb. 27, 2018 /CNW/ - Innovative Medicines Canada and its member companies welcome the appointment of Dr. Eric Hoskins as the Chair of the Advisory Council on the Implementation of National Pharmacare and look forward to working closely with all stakeholders.
"We are keen to engage in the national dialogue on how best to move forward to ensure all Canadians have fair, equitable and affordable access to the medicines they need, when they need them," said Innovative Medicines Canada President Pamela Fralick. "We believe in closing the gaps in coverage to help those who are uninsured and underinsured."
Innovative Medicines Canada's priority is to ensure the health systems achieve best outcomes by providing access to a full range of medicines to meet each patient's unique needs. Any solution needs to ensure that everyone has access to the most effective treatment options.
FUNDING FOR SCIENCE AND RESEARCH
Innovative Medicines Canada applauds the significant investment to support the next generation of researchers, granting councils, Canada Research Chairs, big data and federal science and technology facilities, while strengthening support for entrepreneurs to innovate, scale up and reach global markets.
The innovative pharmaceutical industry is a natural partner to the Government's plan to strengthen Canada's record on innovation and foster health research and development right here at home. According to a 2017 analysis by EY, Innovative Medicines Canada members generate $19 billion in economic activity, invest $1.2 billion annually into R&D to stimulate innovation and support 30,000 high value jobs.
ABOUT INNOVATIVE MEDICINES CANADA
Innovative Medicines Canada is the national voice of Canada's innovative pharmaceutical industry. We advocate for policies that enable the discovery, development and commercialization of innovative medicines and vaccines that improve the lives of all Canadians. We support our members' commitment to being valued partners in the Canadian healthcare system.
SOURCE Innovative Medicines Canada
For further information: Sarah Dion-Marquis, Director, Media and Public Relations, Telephone: 613-769-6510, E-mail: [email protected]